Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Sep 15;16(18):4493-5.
doi: 10.1158/1078-0432.CCR-10-1548. Epub 2010 Jul 19.

Volumes to learn: advancing therapeutics with innovative computed tomography image data analysis

Michael L Maitland  1
Affiliations
Comment

Volumes to learn: advancing therapeutics with innovative computed tomography image data analysis

Michael L Maitland. Clin Cancer Res. .

Abstract

Semi-automated methods for calculating tumor volumes from computed tomography images are a new tool for advancing the development of cancer therapeutics. Volumetric measurements, relying on already widely available standard clinical imaging techniques, could shorten the observation intervals needed to identify cohorts of patients sensitive or resistant to treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Tumor volume change as an early response metric
Early response assessment is limited by smaller magnitude changes than seen with conventionally timed response assessment (top). Volume measurement may allow detection of antitumor effect when it is not apparent with conventional diameter measurement (bottom).
See this image and copyright information in PMC

Comment on

References

    1. Zhao B, Oxnard GR, Moskowitz CS, et al. A Pilot Study of Volume Measurement as a Method of Tumor Response Evaluation to Aid Biomarker Development. Clin Cancer Res. 2010 June 9; doi: 10.1158/1078-0432.CCR-10-0125. - DOI - PMC - PubMed
    1. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer. 2009;45:228–47. - PubMed
    1. Moertel CG, Hanley JA. The effect of measuring error on the results of therapeutic trials in advanced cancer. Cancer. 1976;38:388–94. - PubMed
    1. Lavin PT. An alternative model for the evaluation of antitumor activity. Cancer Clin Trials. 1981;4:451–7. - PubMed
    1. Karrison TG, Maitland ML, Stadler WM, Ratain MJ. Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer. J Natl Cancer Inst. 2007;99:1455–61. - PubMed

MeSH terms